Cristin-resultat-ID: 1023047
Sist endret: 21. januar 2015 15:28
Resultat
Rapport
2013

Diffusion of Pharmaceuticals: Cross-Country Evidence of Anti-TNF drugs

Bidragsytere:
  • Kurt Brekke
  • Dag Morten Dalen og
  • Tor Helge Holmås

Utgiver/serie

Utgiver

Department of Economics, Norwegian School of Economics

Serie

NHH Dept. of Economics Discussion papers
ISSN 0804-6824

Om resultatet

Rapport
Publiseringsår: 2013
Hefte: 7
Antall sider: 23

Beskrivelse Beskrivelse

Tittel

Diffusion of Pharmaceuticals: Cross-Country Evidence of Anti-TNF drugs

Sammendrag

This paper studies the di¤usion of biopharmaceuticals across European countries, focusing on anti-TNF drugs, which are used to treat autoimmune diseases (e.g., rheumatism, psoriasis). We use detailed sales information on the three brands Remicade, Enbrel and Humira for nine European countries covering the period from the fi…rst launch in 2000 until becoming blockbusters in 2009. Descriptive statistics reveal large variations across countries in per-capita consumption and price levels both overall and at brand level. We explore potential sources for the cross-country consumption differences by estimating several multivariate regression models. Our results show that large parts of the cross-country variation are explained by time-invariant country-speci…c factors (e.g., disease prevalence, demographics, health care system). We also fi…nd that differences in income (GDP per capita) and health spending (share of GDP) explain the cross-country variation in consumption, while relative price differences seem to have limited impact.

Bidragsytere

Kurt Richard Brekke

Bidragsyterens navn vises på dette resultatet som Kurt Brekke
  • Tilknyttet:
    Forfatter
    ved Institutt for samfunnsøkonomi ved Norges Handelshøyskole

Dag Morten Dalen

  • Tilknyttet:
    Forfatter
    ved Institutt for samfunnsøkonomi ved Handelshøyskolen BI

Tor Helge Holmås

  • Tilknyttet:
    Forfatter
    ved NORCE Samfunn ved NORCE Norwegian Research Centre AS
1 - 3 av 3